The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...

A drug cost analysis expert reveals that the life-saving drug Risdiplam, used to treat the rare genetic disease SMA, could ...

About 18.7 million people will save $7.4 billion next year alone thanks to changes to Medicare drug benefits, the ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

Stuart Staggs, vice president of transformation and shared services at McKesson, explained that oncology practices in the ...

PROCEEDS to the State from the planned sale of the alleged drug trafficking ship MV Matthew are set to be largely wiped out ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

A coalition of state attorneys general, including those in Pennsylvania and New Jersey, has reached agreements with two ...

Business owners in downtown Fredericton say they are increasingly frustrated with a rise in break-ins, theft, vandalism, open ...

I have a real problem with the science behind the DRE,” said attorney Chris Langholz. “It’s junk science and it shouldn’t be ...

Walgreens was accused of wrongly requiring insured customers to pay more than members of its Prescription Savings Club.

Walgreens has agreed to pay $100 million to settle a proposed class action lawsuit accusing it of fraudulently overcharging ...